| Similar Articles |
|---|
 |
The Motley Fool
March 23, 2004
W.D. Crotty |
Down on Drug News? An FDA advisory on labeling antidepressants shouldn't depress drug stocks.   |
The Motley Fool
June 3, 2004
Brian Gorman |
Spitzer Chases Glaxo Did the drug company GlaxoSmithKline withhold information about the effects of Paxil in children? No doubt the bad publicity will continue to hit the stock. |
The Motley Fool
November 19, 2008
Brian Orelli |
Depressing News for Drugmakers Antidepressants aren't that different from each other, says a recent report. |
The Motley Fool
December 29, 2003
Alyce Lomax |
Lilly's Symbyax Gets Green Light Prozac has a new lease on life. The Food and Drug Administration recently approved Eli Lilly's well-known antidepressant in combination with Zyprexa for the treatment of bipolar depression. |
The Motley Fool
February 20, 2004
Alyce Lomax |
A Downer for Lilly? The pharmaceutical giant confirms warnings on Zyprexa and the elderly. That warning had to do with a higher incidence of stroke in elderly users suffering from dementia. |
The Motley Fool
September 30, 2010
Brian Orelli |
Avoid This Multibillion-Dollar Market It's just too crowded, but there's no doubt that psychiatric drugs are big business for some drugmakers. |
The Motley Fool
July 11, 2008
Brian Orelli |
Pfizer Looking at a Level Playing Field An advisory panel says that epilepsy drugs don't need a black-box warning, news that is positive for drug companies -- that is, those other than Pfizer. |
The Motley Fool
November 30, 2009
Brian Orelli |
Anxious No Longer Eli Lilly adds another approval onto Cymbalta. |
The Motley Fool
January 25, 2011
Brian Orelli |
FDA Approved -- Now Will It Sell? There's still plenty of uncertainty in Clinical Data's shares. |
BusinessWeek
April 26, 2004
Carol Marie Cropper |
A Cloud Over Antidepressants Do some popular drugs cause suicidal behavior in teens? |
Wired
September 25, 2007
Patrick Di Justo |
From Benzedrine to Abilify, Chronicling America's Love of Psychiatric Drugs A history of what Americans have used to battle depression. |
The Motley Fool
February 12, 2004
Alyce Lomax |
Depressing Year for Glaxo The pharmaceutical giant forecasts three lackluster quarters as copycats attack. |
Managed Care
October 2004 |
Pediatric Antidepressant Use Drops 18 Percent After an FDA advisory warned health care providers that some children and teenagers can become suicidal when prescribed antidepressants, the percentage of eligible patients taking these agents dropped considerably. |
ifeminists
October 5, 2008
Tony Zizza |
The over-prescribing of America In writing "Stigma often hinders lifesaving discussion" for The Tennessean on Sept. 17, Dr. Dennis Morrison offers us more recycled bromides concerning suicide and the state of mental health. |
The Motley Fool
January 19, 2007
Billy Fisher |
The Best Drug Stock for 2007: Forest Laboratories Management shows confidence in its company, which has been busy with expansion. Investors, take note. |
BusinessWeek
June 26, 2008 |
Antidepressant Risks No governing body obliges doctors to tell patients about industry payments. Senator Charles Grassley has introduced legislation that would require pharmaceutical companies to reveal on a Web site any such payments. |
The Motley Fool
January 21, 2004
Alyce Lomax |
Forest Labs' High Hopes Alzheimer's treatment drug Namenda seems to be Forest's strong suit. |
American Family Physician
January 1, 2007 |
Depression in Children and Teens How to recognize depression in your children and resources available for more information. |
The Motley Fool
January 5, 2004
Alyce Lomax |
Side Effects at Lilly? Growing profits, with earnings pains. |
American Family Physician
January 1, 2007
Shashi & Subhash Bhatia |
Childhood and Adolescent Depression Safe and effective treatment of major depression in this age group requires accurate diagnosis, suicide risk assessment, and use of evidence-based therapies. |
The Motley Fool
October 24, 2008
Brian Orelli |
Lilly's Results Run the Gamut The company's GAAP EPS and adjusted EPS are at polar extremes. |
AskMen.com
January 6, 2001
Joshua Levine |
Dealing With Depression Clinical depression is an illness characterized by a cluster of feelings, thoughts and behaviors that are strikingly different from a person's normal range of feeling and functioning... |
The Motley Fool
March 23, 2009
Brian Orelli |
Good News for Eli Lilly's Depression Drug Eli Lilly announces that the Food and Drug Administration has expanded the label of Symbyax to treat patients with treatment-resistant depression, meaning they haven't been helped by at least two other drugs. |
Reason
October 2005
Maia Szalavitz |
In Defense of Happy Pills While psychotherapy validated by research has its place, there is no convincing reason why it should be considered inherently superior to drugs. Pleasure can be just as important for emotional recovery and growth as pain, if not more so. |
American Family Physician
October 15, 2006 |
Depression: What You Should Know A patient guide: What is depression?... What causes depression?... Symptoms of Depression... How is depression diagnosed?... etc. |
The Motley Fool
April 19, 2004
Alyce Lomax |
Eli Lilly's Drug Dependency Competitive concerns make Cymbalta and new drugs more important than ever. |
The Motley Fool
March 16, 2007
Billy Fisher |
Challenge Awaits Biovail The company's popular Wellbutrin XL will be facing generic competition soon. Biovail is currently trading 36% below its 52-week high. |
The Motley Fool
January 27, 2009
Robert Steyer |
Another Angle for Fibromyalgia In the past 18 months, the FDA has approved three drugs that can be used to treat the disease. Which pharma companies will benefit? |
Nurse Practitioner
March 2012
Vanya Hamrin et al. |
Evaluation and Management of Pediatric and Adolescent Depression The primary care setting is an appropriate venue for screening and identifying pediatric depression. Nurse practitioners can provide initial management or referral to psychiatric mental health professionals for evidence-based treatments. |
Salon.com
July 11, 2001
Amy Benfer |
A history of failure Author and psychologist Bruce Levine pummels psychiatry, psychotropic drugs and the role both may have played in the case of Andrea Yates... |
ifeminists
April 29, 2004
Tony Zizza |
Stop Selling Depression and Drugs To Men Author questions how it can be wrong to profile terrorists, but okay to profile a particular gender as a profitable market for medications and subjective mental health labels? |
ifeminists
December 28, 2005
Tony Zizza |
If Depression Hurts, Eli Lilly Is Killing Us Eli Lilly's latest marketing campaign is a form of propaganda that speaks to how low Big Pharma will go to keep Americans in chemical handcuffs. |
Chemistry World
February 26, 2008
James Mitchell Crow |
Q and A: Do Antidepressants Work? A widely-reported analysis of clinical trial data for Prozac and related antidepressant drugs has claimed that the medicines work little better than chemically-inactive placebos in all but the most severely depressed patients. |
American Family Physician
August 1, 2006
Warner et al. |
Antidepressant Discontinuation Syndrome Antidepressant discontinuation syndrome occurs in approximately 20% of patients after abrupt discontinuation of an antidepressant medication that was taken for at least six weeks. |
The Motley Fool
April 20, 2004
Alyce Lomax |
Pfizer's Fight First-quarter earnings give mixed messages on the drug maker's meds. |
The Motley Fool
November 5, 2010
Brian Orelli |
Better Late Than Never for Cymbalta Eli Lilly gets an expanded approval for Cymbalta. |
The Motley Fool
April 21, 2004
Ben McClure |
Discount Pharmacy With prices beaten down across the pharmaceuticals industry and the quarterly reporting season here, do any investment opportunities pop up? |
The Motley Fool
April 16, 2008
Brian Orelli |
Forest Labs' Race Against the Clock Investors don't seem to like Forest Labs' ambitious plans for research and development. |
The Motley Fool
September 1, 2004
W.D. Crotty |
A Pall Falls Over Forest One of Forest Labs' Alzheimer's drugs fails in phase 3 trials. For investors willing to take the political risk, today's drug news has taken a battered stock, with a great balance sheet, to very reasonable price levels. |
The Motley Fool
August 18, 2010
Brian Orelli |
More Pain Ahead for Eli Lilly? An advisory panel meeting tomorrow could further the company's slide. |
Nursing
May 2010
Sharon M. Valente |
Assessing patients for suicide risk This article will help you update your knowledge of suicide risk factors and prevention strategies, and provide guidelines for effective intervention. |
ifeminists
June 23, 2004
Tony Zizza |
Poor Parenting Skills Can Be A Choice It's time for Americans to start improving parenting skills from within. Stop allowing the pharmaceutical companies with their magic pills, brochures and videos to do what we alone must do - raise our children. |
American Family Physician
September 15, 2002 |
Depression What is depression?... What causes depression?... How is depression diagnosed?... How is depression treated?... What about suicide?... |
American Family Physician
September 15, 2002 |
Depression in Women Is depression common in women?... What are the symptoms?... What causes depression?... Symptoms of Depresssion... How is depression treated?... Are antidepressants safe for any woman with depression?... etc. |
The Motley Fool
December 8, 2004
Alyce Lomax |
Eli Lilly Bares All The pharmaceutical publishes clinical trial results online. This is a step toward generating trust -- after all, shareholders, physicians, and consumers alike are likely looking askew at Big Pharma these days. |
ifeminists
May 5, 2004
Tony Zizza |
Depression Screenings Don't Belong In Our Schools A recent article in the Denver Post reports Denver Health's School-Based Health Centers are screening every student - for depression - who steps inside any one of the 11 school-based "clinics." |
The Motley Fool
April 24, 2007
Ryan Fuhrmann |
Mixed Foliage at Forest Labs Here's what to look for as Forest Labs prepares for a big loss. Investors, take note. |
Nursing
April 2008
Kathryn Murphy |
Shedding the burden of depression & anxiety Learn about types of depression and available treatments. |
Reason
April 2004
Joli Jensen |
Emotional Choices What story you choose to believe about antidepressants reveals a deeper truth about who you are. |
Salon.com
March 9, 2000
Lawrence H. Diller, M.D. |
Kids on drugs A behavioral pediatrician questions the wisdom of medicating our children. |
